Evidence map›Paper›PMID 32519380›Full record

ArticleGenetic epidemiology2020

Sequencing and imputation in GWAS: Cost-effective strategies to increase power and genomic coverage across diverse populations.

Corbin Quick, Pramod Anugu, Solomon Musani, Scott T Weiss, Esteban G Burchard, Marquitta J White, Kevin L Keys, Francesco Cucca, Carlo Sidore, Michael Boehnke and 1 more

Abstract read
In one paragraph

Article in Genetic epidemiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Imputation of ancient canid genomes reveals inbreeding history over the past 10,000 years.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Corbin QuickDepartment of Biostatistics and Center for Statistical Genetics, University of Michigan School of Public Health, Ann Arbor, Michigan.
Pramod AnuguUniversity of Mississippi Medical Center, Jackson, Mississippi.
Solomon MusaniUniversity of Mississippi Medical Center, Jackson, Mississippi.
Scott T WeissHarvard Medical School, Boston, Massachusetts.
Esteban G BurchardDepartment of Medicine, University of California San Francisco, San Francisco, California.
Marquitta J WhiteDepartment of Medicine, University of California San Francisco, San Francisco, California.
Kevin L KeysDepartment of Medicine, University of California San Francisco, San Francisco, California.
Francesco CuccaIstituto di Ricerca Genetica e Biomedica (IRGB), CNR, Monserrato, Italy.
Carlo SidoreIstituto di Ricerca Genetica e Biomedica (IRGB), CNR, Monserrato, Italy.
Michael BoehnkeDepartment of Biostatistics and Center for Statistical Genetics, University of Michigan School of Public Health, Ann Arbor, Michigan.
Christian FuchsbergerDepartment of Biostatistics and Center for Statistical Genetics, University of Michigan School of Public Health, Ann Arbor, Michigan.ORCID 0000-0002-5918-8947

Funding

Clinical and Translational Science InstituteUL1TR001872 · NCATS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI COLLARD, HAROLD R, JACOBY, VANESSA · 2016 to 2025
$112.1M
Regional Pilot And Feasibility Study Grants ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Scott Soleimanpour · 2013 to 2026
$24.3M
University of Michigan Training Program in Genomic ScienceT32HG000040 · NHGRI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Sebastian Zoellner · 1995 to 2026
$16.4M
SF BUILD: Enabling Students to Represent in ScienceRL5GM118984 · NIGMS · SAN FRANCISCO STATE UNIVERSITY · PI MARQUEZ-MAGANA, LETICIA MARIA, MORRIS, MEGHAN D · 2015 to 2023
$5.2M
Design and Analysis of Human Gene Mapping StudiesR01HG009976 · NHGRI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BOEHNKE, MICHAEL L · 2018 to 2022
$2.5M
Integrative Genetics and Genomics of Obese-Asthma in Minority ChildrenK01HL140218 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WHITE, MARQUITTA · 2018 to 2020
$457k
Design and Analysis of Human Gene Mapping StudiesR56HG000376 · NHGRI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BOEHNKE, MICHAEL L · 2017 to 2017
$400k
Medical Research Council G0601261Medical Research Council G0601966Medical Research Council G0700931Medical Research Council G0900747NCATS NIH HHS UL1 TR001872NHGRI NIH HHS R01 HG009976NHGRI NIH HHS R56 HG000376NHGRI NIH HHS T32 HG000040NHLBI NIH HHS K01 HL140218NIDA NIH HHS HHSN271201100005CNIDDK NIH HHS P30 DK020572NIGMS NIH HHS RL5 GM118984NIH HHS N01-AG-1-2109
6 · The paper itself

Abstract

A key aim for current genome-wide association studies (GWAS) is to interrogate the full spectrum of genetic variation underlying human traits, including rare variants, across populations. Deep whole-genome sequencing is the gold standard to fully capture genetic variation, but remains prohibitively expensive for large sample sizes. Array genotyping interrogates a sparser set of variants, which can be used as a scaffold for genotype imputation to capture a wider set of variants. However, imputation quality depends crucially on reference panel size and genetic distance from the target population. Here, we consider sequencing a subset of GWAS participants and imputing the rest using a reference panel that includes both sequenced GWAS participants and an external reference panel. We investigate how imputation quality and GWAS power are affected by the number of participants sequenced for admixed populations (African and Latino Americans) and European population isolates (Sardinians and Finns), and identify powerful, cost-effective GWAS designs given current sequencing and array costs. For populations that are well-represented in existing reference panels, we find that array genotyping alone is cost-effective and well-powered to detect common- and rare-variant associations. For poorly represented populations, sequencing a subset of participants is often most cost-effective, and can substantially increase imputation quality and GWAS power.

Indexed as

Genome, HumanGenome-Wide Association StudyWhole Genome SequencingCost-Benefit AnalysisGene FrequencyGenotypeHumansPhenotypePolymorphism, Single Nucleotidegenotype imputationgenotypingGWASrare variantssequencingstudy designWGS

Identifiers

PMID32519380
PMCPMC7449570

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.